Delivery Order SPE2DB24D9131-SPE2DB25FXRT6
- Not listed
- The U.S. government agency, the Defense Logistics Agency (DLA), awarded a $1,547.40 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a period of performance through September 25, 2024, and is for the provision of the pharmaceutical product Xolair 150 mg/mL syringe. This delivery order is placed under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at eleven thousand six hundred five dollars and fifty cents ($11,605.50) by the Defense Logistics Agency. This order was issued against DMS Pharmaceutical Group's indefinite delivery contract to supply pharmaceutical items and medical products to the Defense Logistics Agency with a potential value of up to five million dollars through December 2025. Under this order, DMS Pharmaceutical Group will deliver...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,642.20 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of Xolair 150 mg/ml syringes, a specialized pharmaceutical product. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which provides a wide range of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $37,137.60 contract is for the delivery of Xolair 150 mg/mL syringes to support the recurring medical supply needs of military health facilities. This award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999,...
- The Defense Logistics Agency (DLA) awarded a delivery order contract worth $30,948.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the provision of Xolair 150 mg/ml syringes, a specialty pharmaceutical product, with a period of performance through June 11, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which allows...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $11,605.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML, a specialized pharmaceutical product, with a period of performance through August 16, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,547.40 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 150 mg/mL XOLAIR syringes and does not have a set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price delivery orders for a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,474.00 firm fixed-price delivery order is for the supply of XOLAIR 150 MG/ML SYRINGEML, a specialized pharmaceutical product, with a period of performance through January 2, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $22,325.76 by the Defense Logistics Agency's Medical Supply Chain on August 22, 2025. The contract calls for the delivery of Xolair 300 mg/2 ml syringes and is expected to be completed by September 15, 2025. This delivery order was issued without a set-aside designation, demonstrating the company's competitive standing in...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml syringes. This firm fixed-price delivery order, valued at $1,547.40 with an ultimate completion date of September 10, 2025, was issued without set-aside designation. DMS Pharmaceutical Group competes effectively in federal procurement leveraging its small business status and established...
- SPE2DB24D9131Indefinite Delivery Contract
- SPE2DB24D9131-SPE2DB25FXRT6Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,547.40 by the Defense Logistics Agency (DLA) on August 29, 2025. The delivery order, which has an ultimate completion date of September 22, 2025, is for XOLAIR 150 mg/ml syringes. This award was made without a set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open federal procurement market. The contract represents a direct supply arrangement supporting the pharmaceutical needs of Department of Defense healthcare facilities. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This master contract enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables. Through this established vehicle, DMS Pharmaceutical Group serves as a critical supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription medications and specialty products to military health facilities nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/29/25 |